The use of neck ultrasounds, radioiodine scans, and PET scans in people diagnosed with thyroid cancer was associated with additional treatment for recurrence.
![Color-enhanced cross sectional CT image of the neck showing a nodule (large round red density) in the right lobe of the thyroid gland (purple).](https://www.enttoday.org/wp-content/uploads/2016/06/ENT_0616_pg6a-145x85.png)
The use of neck ultrasounds, radioiodine scans, and PET scans in people diagnosed with thyroid cancer was associated with additional treatment for recurrence.
Does PET impact staging and survival in head and neck cancer?
How does combined positron emission tomography and computed tomography (PET/CT) compare with CT and magnetic resonance imaging (MRI) for monitoring head and neck cancer?
PET combined with CT might be one of the most powerful imaging technologies available, but how effective it is in evaluating head and neck tumors and helping with treatment is not a cut-and-dried proposition, said Jonas Johnson, MD, in his State of the Art Lecture at the 115th Annual Meeting of the Triological Society, held here on April 20 as part of the Combined Otolaryngology Spring Meetings.
PHOENIX-Just how useful are PET or PET-CT in identifying residual occult nodal disease in patients with head and neck cancer? Two presentations at the 2009 Combined Otolaryngology Spring Meeting addressed this topic.
Head and neck cancer care has been undergoing a paradigm shift over the past decade, moving from a surgery-based approach to one that increasingly relies on chemoradiation (CRT).
Otalgia is a common complaint of patients presenting to both general practice and otolaryngology clinics.
The use of positron emission tomography (PET) is not sensitive enough to warrant routine use in post-curative chemoradiation therapy diagnosis of patients with node-positive head and neck cancer, according to researchers in the field.